1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Kardiol Pol. 2018;76(4):755-763. doi: 10.5603/KP.2018.0010. Epub 2018 Jan 9.
Risk stratification in acute coronary syndrome (ACS) is usually based on clinical data obtained during hospitalisation. To date, there is a limited number of prospective observational studies assessing long-term prognosis of patients discharged from hospital after ACS.
This study is to investigate long-term follow-up of unselected ACS patients treated at the 24-hour/7-day (24/7) cardiac catheterisation laboratory and discharged from referral university hospital.
We studied 672 consecutive ACS patients (median age 61 years, 66.7% men) hospitalised and discharged between 2002 and 2004. The analysis was done in respect of the type of ACS, i.e. non–ST-segment elevation: unstable angina non-ST-segment elevation myocardial infarction (UA/NSTEMI; n = 255) vs. ST-segment elevation myocardial infarction (STEMI; n = 417). All patients underwent coronarography and, if indicated, primary angioplasty (417 patients with STEMI and 157 patients with UA/NSTEMI). The primary endpoint was defined as all-cause mortality during six years of follow-up. Survival status and date of death were obtained from the National Death Registry of Poland and presented as Kaplan–Meier survival curves.
Despite a significantly higher one-year mortality of patients with UA/NSTEMI compared to those with STEMI (7.1% vs. 3.1%, p = 0.018), the overall mortality assessed throughout follow-up until 2009 was comparable between UA/NSTEMI and STEMI patients (18.8% vs. 18%, p = 0.79).
The long-term (several years) survival did not depend on the type of ACS.
急性冠状动脉综合征(ACS)的风险分层通常基于住院期间获得的临床数据。迄今为止,只有少数前瞻性观察研究评估 ACS 患者出院后的长期预后。
本研究旨在调查在 24 小时/7 天(24/7)心脏导管实验室接受治疗并从转诊大学医院出院的未选择 ACS 患者的长期随访情况。
我们研究了 2002 年至 2004 年期间住院和出院的 672 例连续 ACS 患者(中位年龄 61 岁,66.7%为男性)。分析的依据是 ACS 的类型,即非 ST 段抬高:不稳定型心绞痛非 ST 段抬高型心肌梗死(UA/NSTEMI;n=255)与 ST 段抬高型心肌梗死(STEMI;n=417)。所有患者均接受冠状动脉造影检查,如果需要,还进行直接经皮冠状动脉介入治疗(STEMI 患者 417 例,UA/NSTEMI 患者 157 例)。主要终点定义为 6 年随访期间的全因死亡率。生存状态和死亡日期从波兰国家死亡登记处获得,并以 Kaplan-Meier 生存曲线表示。
尽管 UA/NSTEMI 患者的一年死亡率明显高于 STEMI 患者(7.1% vs. 3.1%,p=0.018),但整个随访期间直至 2009 年的总体死亡率在 UA/NSTEMI 和 STEMI 患者之间是可比的(18.8% vs. 18%,p=0.79)。
长期(数年)生存率与 ACS 的类型无关。